The Asia Pacific Transcatheter Aortic Valve Replacement Market would witness market growth of 8.5% CAGR during the forecast period (2022-2028).
A wire valve frame and bovine (cow) animal tissue leaflets comprise the transcatheter aortic valve replacement, intended to repair the damaged aortic valve. A catheter is inserted by the surgeon after making a little incision in an artery or blood vessel, most frequently in the groin. The catheter is squeezed and attached to the artificial valve, inserted into the damaged aortic valve through the blood vessel.
The surgeon will move the defective portions of the aortic valve leaflets out of the way and insert the new valve using cutting-edge imaging methods like X-rays. Once installed, the new valve will work and restore blood flow. The surgeon will next take out the catheter and sew up the wound. The patient will be moved to the recovery area and released a few days later. To stop more blood clots, doctors will give blood-thinning drugs.
Due to the aging population and rising incidence of illnesses, including heart disease and aortic stenosis, the transcatheter aortic valve replacement device market has grown rapidly over the past several years. Furthermore, one or more damaged heart valves may require repair or replacement surgery to address issues. Due to increased awareness of the advantages of aortic valve replacement and the availability of efficient treatments, more patients are pursuing this procedure.
It is anticipated that 34 countries will have over 20% of their population over 65 by 2030 due to the world's aging population. China's population is aging rapidly; as a result of rising life expectancy and falling birth rates, China's population of individuals over 60 is expected to increase to 28% by 2040. In particular, the creation of an integrated system that meets the social and health requirements of older people while ensuring that everyone has access to health care regardless of location is made possible by this enormous demographic transition. A rapidly aging population necessitates the development of age-friendly towns and cities where the elderly can flourish and make valuable contributions to society. To enhance access to integrated care, China has been researching novel strategies. These elements would support the growth of the regional market.
The China market dominated the Asia Pacific Transcatheter Aortic Valve Replacement Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $614.3 million by 2028. The Japan market is estimated to grow a CAGR of 7.8% during (2022 - 2028). Additionally, The India market would experience a CAGR of 9.1% during (2022 - 2028).
Based on Material, the market is segmented into Nitinol, Stainless Steel, Cobalt-Chromium and Others. Based on Implantation Procedure, the market is segmented into Transfemoral, Transapical and Transaortic. Based on Mechanism, the market is segmented into Balloon-expanding Valve and Self-expanding Valve. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Transcatheter Aortic Valve Replacement Market is Projected to reach USD 8 Billion by 2028, at a CAGR of 7.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, MicroPort Scientific Corporation, LivaNova PLC, TTK Healthcare Limited, Meril Life Science Private Limited, JenaValve Technology, Inc., and Bracco S.p.A.
By Material
By Implantation Procedure
By Mechanism
By End-use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 